MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma

Multiple myeloma (MM) remains largely incurable despite significant advances in biotherapy and chemotherapy. The development of drug resistance is a major problem in MM management. Macrophage migration inhibitory factor (MIF) expression was significantly higher in purified MM cells from relapsed pat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood
Main Authors: Wang, Qiang, Zhao, Dongyu, Xian, Miao, Wang, Zhuo, Bi, Enguang, Su, Pan, Qian, Jianfei, Ma, Xingzhe, Yang, Maojie, Liu, Lintao, Zu, Youli, Pingali, Sai Ravi, Chen, Kaifu, Cai, Zhen, Yi, Qing
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2020
Assuntos:
Lymphoid Neoplasia
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714094/
https://ncbi.nlm.nih.gov/pubmed/32582913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005795
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares